Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001193125-26-122267

Options or other derivatives

  • Chief Medical Officer acquired 68,499 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Patel Naimish · Chief Medical Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-03-20 Grant or award : show line 1 in the form Stock Option (Right to Buy) +38,499 38,499 D
2026-03-20 Grant or award : show line 2 in the form Restricted Stock Units +30,000 30,000 D
Loading xslF345X06/ownership.xml…